Methods of preparing cytotoxic benzodiazepine derivatives

US10844078B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10844078-B2
Application numberUS-201916442718-A
CountryUS
Kind codeB2
Filing dateJun 17, 2019
Priority dateJan 25, 2017
Publication dateNov 24, 2020
Grant dateNov 24, 2020

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The invention provides novel methods for preparing indolinobenzodiazepine dimer compounds and their synthetic precursors.

First claim

Opening claim text (preview).

The invention claimed is: 1. A method of preparing a compound of formula (II), comprising reacting a compound of formula (I): with hydrochloric acid in toluene, wherein the hydrochloric acid is 30-38 w/w % of hydrochloric acid in water, and wherein the compound of formula (II) is purified by crystallization by cooling a concentrated solution of the compound in toluene. 2. A method of preparing a compound of formula (IV-1): or a salt thereof, comprising the steps of: 1) reacting a compound of formula (I): with hydrochloric acid in toluene to form a compound of formula (II), wherein the hydrochloric acid is 30-38 w/w % of hydrochloric acid in water: and wherein the compound of formula (II) is purified by crystallization by cooling a concentrated solution of the compound in toluene; 2) reacting the compound of formula (II) with a monomer compound of formula (a) in the presence of an alcohol activating agent and an azodicarboxylate, to form a compound of formula (III): or a salt thereof, wherein the alcohol activating agent is a trialkylphosphine, triarylphosphine, or triheteroarylphosphine, and wherein the azodicarboxylate is selected from the group consisting of: diethyl azodicarboxylate (DEAD), diisopropyl azodicarboxylate (DIAD), 1,1′-(azodicarbonyl)dipiperidine (ADDP), and ditertbutyl azodicarboxylate (DTAD); 3) reacting the compound of formula (III) or a salt thereof with a monomer compound of formula (b) in the presence of a base: to form the compound of formula (IV-1) or a salt thereof, wherein the base is sodium carbonate, potassium carbonate, cesium carbonate, sodium hydride, or potassium hydride. 3. A method of preparing a compound of formula (A-1): or a salt thereof, comprising the steps of: 1) reacting a compound of formula (I): with hydrochloric acid in toluene to form a compound of formula (II), wherein the hydrochloric acid is 30-38 w/w % of hydrochloric acid in water: and wherein the compound of formula (II) is purified by crystallization by cooling a concentrated solution of the compound in toluene; 2) reacting the compound of formula (II) with a monomer compound of formula (a) in the presence of an alcohol activating agent and an azodicarboxylate, to form a compound of formula (III): or a salt thereof, wherein the alcohol activating agent is a trialkylphosphine, triarylphosphine, or triheteroarylphosphine, and wherein the azodicarboxylate is selected from the group consisting of: diethyl azodicarboxylate (DEAD), diisopropyl azodicarboxylate (DIAD), 1,1′-(azodicarbonyl)dipiperidine (ADDP), and ditertbutyl azodicarboxylate (DTAD); 3) reacting the compound of formula (III) or a salt thereof with a monomer compound of formula (b) in the presence of a base: to form a compound of formula (IV-1): or a salt thereof, wherein the base is sodium carbonate, potassium carbonate, cesium carbonate, sodium hydride, or potassium hydride; 4) reacting the compound of formula (IV-1) or a salt thereof with a reducing agent to form a compound of formula (V-1): or a salt thereof; and 5) reacting the compound of formula (V-1) or a salt thereof, with a compound of formula (X-1): to form the compound of formula (A-1) or a salt thereof, wherein E is OH, halide or —C(═O)E is an activated ester. 4. The method of claim 1 , wherein the reaction between the compound of formula (I) and hydrochloric acid is carried out at a temperature between 40° C. and 105° C. 5. The method of claim 4 , wherein the reaction is carried out at a temperature between 90° C. and 100° C. 6. The method of claim 2 , wherein the alcohol activating agent is triphenylphosphine and the azodicarboxylate is diisopropyl azodicarboxylate (DIAD). 7. The method of claim 2 , wherein the reaction of step 2) comprises the steps of i) mixing the alcohol activating agent and the azodicarboxylate to form an alcohol activating agent-azodicarboxylate complex; ii) reacting the compound of formula (II) with the alcohol activating agent-azodicarboxylate complex to form a mixture of the compound of formula (II) and the alcohol activating agent-azodicarboxylate complex; and iii) reacting the mixture of step ii) with the monomer compound of formula (a). 8. The method of claim 2 , wherein in step 3), the base is potassium carbonate. 9. The method of claim 8 , wherein in step 3), the reaction between the compound of formula (III) or a salt thereof and the monomer compound of formula (b) is carried out in the presence of potassium iodide. 10. The method of claim 3 , wherein in step 4), the reducing agent is Fe/NH 4 Cl. 11. The method of claim 3 , wherein the compound of formula (X-1) is represented by formula (X-1a): and the compound of formula (X-1a) or a salt thereof is prepared by a method comprising the steps of: a) reacting a compound of formula (VI): or a salt thereof, with a compound of formula (d) in the presence of an activating agent: or a salt thereof, to form a compound of formula (VII): or a salt thereof; b) reacting the compound of formula (VII) or a salt thereof with a carboxylic acid deprotecting agent to form a compound of formula (VIIIa): or a salt thereof; c) reacting the compound of formula (VIIIa) or a salt thereof with a compound of formula (c-1) in the presence of an activating agent:

Assignees

Inventors

Classifications

  • Dimeric indole alkaloids, e.g. vincaleucoblastine · CPC title

  • C07D519/00Primary

    Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00 · CPC title

  • Ortho-condensed systems · CPC title

  • with hydrocarbon radicals, substituted by hetero atoms, directly attached to the ring nitrogen atom · CPC title

  • C07C205/19Primary

    having nitro groups bound to carbon atoms of six-membered aromatic rings and hydroxy groups bound to acyclic carbon atoms · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10844078B2 cover?
The invention provides novel methods for preparing indolinobenzodiazepine dimer compounds and their synthetic precursors.
Who is the assignee on this patent?
Immunogen Inc
What technology area does this patent fall under?
Primary CPC classification C07D519/00. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Nov 24 2020 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 2 related publications on this page (citations in our corpus or others sharing the same primary CPC).